BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The Company's first product, PURE EP (tm) System, is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.
| Revenue (Most Recent Fiscal Year) | $0.04M |
| Net Income (Most Recent Fiscal Year) | $-10.33M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 4435.44 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 59.85 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -37400.00% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -5336.99% |
| Return on Assets (Trailing 12 Months) | -398.16% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.37 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.37 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.09 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.14 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.75 |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 27.30M |
| Free Float | 22.65M |
| Market Capitalization | $177.41M |
| Average Volume (Last 20 Days) | 1.06M |
| Beta (Past 60 Months) | 1.66 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 17.03% |
| Percentage Held By Institutions (Latest 13F Reports) | 7.16% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |